Downregulation of STOX1 is a novel prognostic biomarker for glioma patients
Storkhead box 1 (STOX1) is a winged helix transcription factor structurally and functionally related to the forkhead family of transcription factors. Recent studies have highlighted its role in the central nervous system and revealed hints in the development of glioma. However, the expression profil...
Guardado en:
Autores principales: | Jin Fei-qin, Jin Lei, Wang Yan-ling |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a58a2753be44cc399ae515e67951364 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical and Prognostic Implications of 1p/19q, IDH, BRAF, MGMT Promoter, and TERT Promoter Alterations, and Expression of Ki-67 and p53 in Human Gliomas
por: Yang Z, et al.
Publicado: (2021) -
Assessment of Prognostic Value of Aspartate Aminotransferase-to-Platelet Ratio Index in Patients With Hepatocellular Carcinoma: Meta-Analysis of 28 Cohort Studies
por: XinYue Zhang, et al.
Publicado: (2021) -
Sarcopenia’s Prognostic Impact on Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Donggun Lee, et al.
Publicado: (2021) -
Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas
por: Liguo Ye, et al.
Publicado: (2021) -
Prognostic impact of microsatellite instability in gastric cancer
por: Cesar Zepeda-Najar, et al.
Publicado: (2021)